Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 11/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.69 |
| ▸ | DPP4 | P27487 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.69 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.69 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.69 |
| ▸ | GAPDH | P04406 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.69 |
| ▸ | STAT6 | P42226 | 1/20 | 0.69 |
| ▸ | PI4KA | P42356 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.69 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.69 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.69 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5'-Deoxyadenosine SCHEMBL542617 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL3459556 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL14158945 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL3459552 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL15926823 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL17677150 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL12453581 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| 5'-Deoxyadenosine SCHEMBL14304623 | 1.00 | AHCY (0.69) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| SCHEMBL4850058 | 0.99 | AHCY (0.67) | AHCYADORA3ADORA2AADORA2BDPP4 | |
| SCHEMBL6674526 | 0.99 | AHCY (0.67) | AHCYADORA3ADORA2AADORA2BDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0787138-A4 | RADIOACTIVE PHOSPHOROUS LABELING OF PROTEINS FOR TARGETED RADIOTHERAPY | IMMUNOMEDICS INC (US) | 2000-03-08 | — | — | EP | claimed |
| US-5976492-A | Radioactive phosphorus labeled proteins for targeted radiotherapy | IMMUNOMEDICS, INC. (US) | 1999-11-02 | — | — | US | claimed |
| US-5728369-A | Radioactive phosphorus labeling of proteins for targeted radiotherapy | IMMUNOMEDICS, INC. (US) | 1998-03-17 | — | — | US | claimed |
| EP-0787138-A1 | RADIOACTIVE PHOSPHOROUS LABELING OF PROTEINS FOR TARGETED RADIOTHERAPY | Immunomedics, Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| WO-1996011208-A1 | RADIOACTIVE PHOSPHOROUS LABELING OF PROTEINS FOR TARGETED RADIOTHERAPY | IMMUNOMEDICS, INC. (US) | 1996-04-18 | — | — | WO | claimed |
| EP-4722358-A1 | GLYCEROL DEHYDRATASE VARIANT AND USE THEREOF | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2026-04-08 | — | — | EP | disclosed |
| US-12522800-B2 | Bacterial cultures for increasing vitamin B12 in plants | HINOMAN LTD. (IL) | 2026-01-13 | — | — | US | disclosed |
| EP-4611779-A1 | A PREDICTIVE SCORE OF CANCER IMMUNOTHERAPY OUTCOME BASED ON ECOLOGICAL ANALYSIS OF GUT MICROBIOTA | Institut Gustave-Roussy (FR) | 2025-09-10 | — | — | EP | disclosed |
| US-12331343-B2 | FAMIN assay methods | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-17 | — | — | US | disclosed |
| WO-2024248535-A1 | GLYCEROL DEHYDRATASE VARIANT AND USE THEREOF | 아주대학교산학협력단 | 2024-12-05 | — | — | WO | disclosed |
| US-20240166675-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY | 2024-05-23 | — | — | US | disclosed |
| WO-2024094817-A1 | A PREDICTIVE SCORE OF CANCER IMMUNOTHERAPY OUTCOME BASED ON ECOLOGICAL ANALYSIS OF GUT MICROBIOTA | INSTITUT GUSTAVE ROUSSY (FR) | 2024-05-10 | — | — | WO | disclosed |
| EP-0946732-A2 | Method for the recombinant production of 1,3-propanediol | GENENCOR INTERNATIONAL, INC. (US) | 1999-10-06 | — | — | EP | disclosed |
| EP-0942989-A1 | METHOD FOR THE PRODUCTION OF 1,3-PROPANEDIOL BY RECOMBINANT ORGANISMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998021339-A1 | METHOD FOR THE PRODUCTION OF 1,3-PROPANEDIOL BY RECOMBINANT ORGANISMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-05-22 | — | — | WO | disclosed |
| WO-1998021341-A2 | METHOD FOR THE RECOMBINANT PRODUCTION OF 1,3-PROPANEDIOL | GENENCOR INTERNATIONAL, INC. (US) | 1998-05-22 | — | — | WO | disclosed |
| US-5728369-A | Radioactive phosphorus labeling of proteins for targeted radiotherapy | IMMUNOMEDICS, INC. (US) | 1998-03-17 | — | — | US | disclosed |
| EP-0037310-B1 | SUBSTITUTED DEOXYADENOSINE DERIVATIVES | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-05-09 | — | — | EP | disclosed |
| US-4374128-A | TREATING RAPID CELL PROLIFERATION | MERRELL TORAUDE ET COMPAGNIE (FR) | 1983-02-15 | — | — | US | disclosed |
| EP-0037310-A1 | Substituted deoxyadenosine derivatives | MERRELL TORAUDE ET COMPAGNIE (FR) | 1981-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166675-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | PPIP5K2, NUDT1, NT5C3B | AHCY 247/4885ADORA3 652/4885ADORA2A 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.